跳至主要内容
临床试验/NL-OMON50284
NL-OMON50284招募中不适用

T-cell response in Lyme disease (TRIL-study) - TRIL-study

Diakonessenhuis Utrecht0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 20 persons with positive Lyme serology who have no symptoms of Borrelia
  • - 20 persons without Lyme symptoms and negative Lyme serology
  • - 50 patients treated for Lyme disease such as acute Lyme neuroborreliosis
  • - 125 patients with active Lyme disease such as acute Lyme neuroborreliosis
  • - 10-20 patients/disease, consisting of patients with active disease known to
  • cross-react with Borrelia such as syphilis, leptospirosis, Epstein-Barr virus
  • (EBV), cytomegalovirus (CMV), Helicobacter pylori, Mycoplasma pneumonia,
  • rheumatoid arthritis (RA) or the presence of antinuclear antibodies (ANA).
  • - informed consent

排除标准

  • * immunosuppressive medication
  • * < 18 years

研究者

相似试验

T-cell response in Lyme disease (TRIL-study) | 临床试验